Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2

Autor: Aliyari, Saba R., Ghaffari, Amir Ali, Pernet, Olivier, Parvatiyar, Kislay, Wang, Yao, Gerami, Hoda, Tong, Ann-Jay, Vergnes, Laurent, Takallou, Armin, Zhang, Adel, Wei, Xiaochao, Chilin, Linda D., Wu, Yuntao, Semenkovich, Clay F., Reue, Karen, Smale, Stephen T., Lee, Benhur, Cheng, Genhong

Publikováno v: In Acta Pharmaceutica Sinica B April 2022 12(4):1624-1635

Factors associated with the availability and affordability of essential cardiovascular disease medicines in low- and middle-income countries: A systematic review.

Autor: Lotfizadeh A; PASHA, Los Angeles, California, United States of America.; Department of Health Services Research and Policy, Centre for Global Chronic Conditions, London School of Hygiene and Tropical Medicine, London, United Kingdom., Palafox B; Department of Health Services Research and Policy, Centre for Global Chronic Conditions, London School of Hygiene and Tropical Medicine, London, United Kingdom., Takallou A; School of Medicine, Oregon Health and Science University, Portland, Oregon, United States of America., Balabanova D; Department of Global Health and Development, Centre for Global Chronic Conditions, London School of Hygiene and Tropical Medicine, London, United Kingdom., McKee M; Department of Health Services Research and Policy, Centre for Global Chronic Conditions, London School of Hygiene and Tropical Medicine, London, United Kingdom., Murphy A; Department of Health Services Research and Policy, Centre for Global Chronic Conditions, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2022 Mar 23; Vol. 2 (3), pp. e0000072. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).